|
Indian Council of Medical Research (ICMR) will provide financial assistance for Indian scientists working outside ICMR institutes to conduct research in medicine, public health and allied disciplines under its extramural research programme.
Research proposals that are aimed at finding solutions for prevention, screening, diagnosis, treatment or rehabilitation of the following diseases or conditions will receive preference for funding in areas of communicable diseases, non-communicable diseases, reproductive, maternal and child health, nutrition.
Communicable diseases under this programme include tuberculosis, antimicrobial resistance, malaria, HIV, sexually transmitted infections, influenza and other respiratory infections, gastrointestinal infections, viral hepatitis, sepsis, meningitis/encephalitis, urinary infections, lymphatic filariasis, kala-azar/leishmaniasis, dengue, helminth infestation , measles, rubella , rickettsia infections (including scrub typhus and non-scrub typhus rickettsia) and Covid.
Non-communicable diseases include cancer – breast, cervix, oral, lung-- diabetes, cardio-vascular disease, COPD, stroke, epilepsy, dementia, chronic kidney disease, depression, anxiety and oral health among others. Reproductive, maternal and child health, nutrition include preconception, hypertensive disorders of pregnancy, intrapartum care, postnatal care, stillbirths, polycystic ovary syndrome and endometriosis.
Research proposals that take forward leads from previous ICMR grants to fruition will also be given preference.
Discovery research, which is aimed at finding novel interventions (basic research), will be considered. Some examples are pre-clinical and phase-I studies including phytopharmaceuticals and traditional medicines and genomic methods/algorithms/tools for personalized medicine, etc.
Development research aimed at developing interventions for screening, diagnosis, prevention, treatment of diseases/conditions or make existing interventions simpler, safer, more efficacious, or more affordable. Examples of such research includes development of Point of care tests, molecular diagnostic tests, animal models for diseases appropriate dosage and formulations, artificial intelligence and machine learning predictive tools/models, phase 2/3 (or equivalent phase) clinical trials of vaccine and therapeutics, etc.
Delivery research or implementation research aimed at learning how to overcome barriers in delivering effective interventions to the people who need them. This will include health system-based interventions to increase access, and to successfully implement national health programmes or schemes, reducing inequity and improving quality of health care.
Descriptive research aimed to understand the disease or condition including its burden, risk factors and determinants and pathogenesis mechanism will not be prioritized and will be funded only if deemed by ICMR to be critical to move towards finding solutions.
The current budgetary ceiling under the programme is Rs. 1.5 crore per project. The project duration will be up to a maximum period of three years. An additional period of up to 6 months for preparatory activities (with no additional costs) can be incorporated in the project proposal.
ICMR scientists are not eligible to apply in this call. ICMR scientists may be named as co-investigators in these projects, but no funds will be given for ICMR institutions or scientists in these cases.
Call for proposals should be well circumscribed and time bound. It should achieve specific and measurable objectives and should be in line with ICMR priorities.
Last date for submission of the proposal is April 28, 2023. Last day for review and selection is June 30, 2023, proposal improvement and final submission of documents is July 31, 2023 and approval and release of funds is till October 31, 2023.
|